USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ADVANCED CELL TECHNOLOGY
Address:
ADVANCED CELL TECHNOLOGY
381 PLANTATION ST
WORCESTER, MA 01605
Phone:
N/A
URL:
N/A
EIN:
10489138
DUNS:
21958041
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $299,261.00 2
STTR Phase I $204,439.00 1

Award List:

CREATION OF CLONED CATTLE LACKING THE PRION GENE

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$99,729.00
Agency:
HHS
Principal Investigator:
Jose B. Cibelli
Abstract:
Not Available Though technology has played a role in the increased retention and educational gains of low-literate adults, much work remains. Researchers in adult education and policymakers have recommended that new instructional technologies with their promise of increased efficiency be pursued.… More

Directed Differentiation of Embryonic Stem Cells using Phage Displayed Ligands

Award Year / Program / Phase:
2006 / STTR / Phase I
Award Amount:
$204,439.00
Agency:
HHS
Principal Investigator:
Research Institution:
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The ability to culture human embryonic stem cells generated a great deal of excitement about their vast potential for treating a variety of human diseases such as diabetes, heart disease, neurological, retinal and skin disorders to name a few. Unlike adult stem… More

Defining Therapeutic Potential of Clonal Stem Cell Populations using Targeted Nan

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$199,532.00
Agency:
HHS
Principal Investigator:
Abstract:
Project Summary Embryonic stem cells offer considerable potential for cell replacement therapy where cells have been lost to injury or disease because of their capacity for continual self renewal and ability to differentiate into virtually any cell type or tissue. Currently, however the process by… More